ARCHIVES

NCAB Seeks Exemption From New Reimbursement Plan For Clinical Trials, Modification Of Hospice Regs

This article is from The Cancer Letter archive.

Vol. 09 No. 06 | February 11, 1983

Download PDF Visit The Full Archive

Related Articles

AVEO’s Tivozanib Sunk by Fundamental Flaw: Higher Overall Survival in the Control Arm

May 8, 2013

In Brief: Shannn Award Selections Made; ACS Funds 431 Grants Worth $50 Mil.; 500 Nurses Pass Exam

August 30, 1991

DCT Board Delays Action On Protein Index, Refuses Support for Cow Study, Approves Various Concepts

October 16, 1981

FDA Spells Out Requirement For INDs For Cancer Drugs.

May 17, 2002

Treanda Approved For B-Cell Non-Hodgkin’s Lymphoma

October 31, 2008

Femara Better Suppressor Of Estrogen, Study Finds

February 22, 2002